Controlled-release pharmaceutical preparation comprising an ACE inhibitor as active ingredient
    1.
    发明授权
    Controlled-release pharmaceutical preparation comprising an ACE inhibitor as active ingredient 失效
    包含ACE抑制剂作为有效成分的控释药物制剂

    公开(公告)号:US06267990B1

    公开(公告)日:2001-07-31

    申请号:US09460055

    申请日:1999-12-13

    IPC分类号: A61K916

    CPC分类号: A61K9/5084 A61K31/401

    摘要: The invention relates to a pharmaceutical preparation which comprises or consists of the following components: (i) an initial dose of active ingredient, which is provided by the active ingredient together with optional excipients, (ii) a first delayed-release type of pellet, in which the active ingredient and optional excipients are covered with a coating, and (iii) a second delayed-release type of pellet, in which the active ingredient and optional excipients are again covered with a coating, wherein the active ingredient is an ACE inhibitor, and wherein the amounts of the coatings according to (ii) and (iii) are present in a ratio, based on weight, within the range of from 1:2 to 1:7.

    摘要翻译: 本发明涉及一种药物制剂,其包含或由以下组分组成:(i)活性成分的初始剂量,其由活性成分与任选的赋形剂一起提供,(ii)第一延迟释放型颗粒, 其中活性成分和任选的赋形剂用涂层覆盖,和(iii)第二延迟释放型颗粒,其中活性成分和任选的赋形剂再次用涂层覆盖,其中活性成分是ACE抑制剂 ,并且其中根据(ii)和(iii)的涂料的量以基于重量在1:2至1:7的范围内的比例存在。

    Active ingredient patch
    3.
    发明授权
    Active ingredient patch 失效
    活性成分补丁

    公开(公告)号:US5683711A

    公开(公告)日:1997-11-04

    申请号:US535038

    申请日:1995-12-15

    摘要: The invention relates to an active ingredient patch in the form of a laminate, the patch comprising a carrier and a matrix of a single polymer and if appropriate another polymer and vitamin E.

    摘要翻译: PCT No.PCT / EP94 / 01231 Sec。 371 1995年12月15日第 102(e)日期1995年12月15日PCT 1994年4月20日PCT PCT。 公开号WO94 / 23707 日期:1994年10月27日本发明涉及层压制品形式的活性成分贴剂,该贴剂包含载体和单一聚合物的基质,如果合适的话,还包括另一种聚合物和维生素E.

    Pharmaceutical preparation with cyclosporin A
    7.
    发明授权
    Pharmaceutical preparation with cyclosporin A 有权
    药物制剂与环孢菌素A

    公开(公告)号:US06696413B2

    公开(公告)日:2004-02-24

    申请号:US09204782

    申请日:1998-12-03

    IPC分类号: C07K764

    CPC分类号: A61K38/13 A61K9/4858

    摘要: The invention relates to a pharmaceutical preparation which consists of or contains cyclosporin A, an emulsifying &agr;-tocopherol derivative, an ethoxylation product of vegetable oils, fatty acids or fats as a further emulsifier and a pharmaceutically customary alcohol.

    摘要翻译: 本发明涉及由环孢菌素A,乳化α-生育酚衍生物,植物油的乙氧基化产物,脂肪酸或脂肪作为其它乳化剂和药学上常规的醇组成或含有的药物制剂。

    Crystalline cyclodextrin complexes of ranitidine hydrochloride, process
for their preparation and pharmaceutical compositions containing the
same
    9.
    发明授权
    Crystalline cyclodextrin complexes of ranitidine hydrochloride, process for their preparation and pharmaceutical compositions containing the same 失效
    雷尼替丁盐酸盐的结晶环糊精复合物,其制备方法和含有它们的药物组合物

    公开(公告)号:US5665767A

    公开(公告)日:1997-09-09

    申请号:US513779

    申请日:1995-12-15

    摘要: The present invention relates to cyclodextrin inclusion complexes of ranitidine hydrochloride which exhibit a novel, to date unknown crystalline structure, being significantly different from those of known "Form 1 and 2" and to the preparation of such inclusion complexes. The inclusion complexes are prepared from aqueous common solution or suspensions of ranitidine hydrochloride and cyclodextrin by removal of water. As complexing agents .alpha.-, .beta.- and gamma-cyclodextrins, their alkylated, hydroxy alkylated derivates or their suitable mixtures are utilized. Finally, the invention concerns pharmaceutical compositions comprising the new complexes.

    摘要翻译: PCT No.PCT / EP94 / 00645 Sec。 371 1995年12月15日第 102(e)日期1995年12月15日PCT 1994年3月4日PCT公布。 WO94 / 20091 PCT出版物 日期1994年9月15日本发明涉及盐酸雷尼替丁的环糊精包合配合物,其显示出迄今为止未知的结晶结构,与已知的“形式1和2”显着不同,并且制备这种包合物。 通过除去水,从盐酸雷尼替丁和环糊精的普通溶液或悬浮液中制备包合物。 作为络合剂α - ,β-和γ-环糊精,使用它们的烷基化羟基烷基化衍生物或其合适的混合物。 最后,本发明涉及包含新配合物的药物组合物。